Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees
复制标题
DOI:
10.1097/meg.0b013e328318ed42
复制
发表时间:
2009-08-01
影响因子:
2.1
通讯作者:
Kim, Young-Woo
中科院分区:
文献类型:
--
作者:
Nam, Su Youn;Choi, Il Ju;Kim, Young-Woo
Objectives Early gastric cancer (EGC) can be treated by minimally invasive endoscopic resection and has an excellent prognosis. The aim of this study was to investigate whether repeated esophagogastroduodenoscopy (EGD) screening is an effective method for detecting EGC that can be treated by endoscopic resection.Methods For patients diagnosed with gastric cancer in the Korean National Cancer Center screening program, we analyzed the incidence of gastric cancer, clinicopathological characteristics, and treatment modality according to whether they had (repeated screening group) or not (infrequent screening group) undergone EGD screening within 2 years before diagnosis.Results Of the 18414 patients who underwent EGD, 81 (0.44%) were found to have gastric cancer. Incidence of gastric cancer in repeated screening group was lower than that of infrequent screening group (multiple adjusted odds ratio=0.45, 95% confidence interval: 0.26-0.77, P=0.004). The proportion of EGCs was 96% (25 of 26) n the repeated screening group and 71% (34 of 48) in the infrequent screening group (P=0.01). Mean (SD) tumor size was smaller [1.9 (1.2) vs. 3.0 (1.6) cm, P=0.01] and the proportion of intramucosal cancer was higher [81% (21 of 26) vs. 50% (24 of 48), P=0.02] in the former than in the latter. Endoscopic resection was performed more frequently in the repeated screening group [54% (14 of 26) vs. 23% (11 of 48), P=0.007].Conclusion Repeated endoscopic screening within 2 years decreased the incidence of gastric cancer and endoscopic resection could be applied to more patients who underwent EGD screening within 2 years. Eur J Gastroenterol Hepatol 21:855-860 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.